---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-009168"
form_type: "8-K"
ticker: "RFAI"
cik: "0002012807"
company_name: "RF Acquisition Corp II"
filed_at: "2026-08-20T20:49:43+00:00"
generated_at: "2026-08-20T20:51:10.349229+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RF Acquisition Corp II shareholders approve Nanyang Biologics deal; 3.96M shares seek redemption

## Summary
- All six proposals approved at Aug 19 EGM: 6,765,584 for, 440,604 against, 0 abstain.
- Preliminary redemption requests for 3,956,323 ordinary shares from trust account (~47.4% of outstanding).
- Business combination with Nanyang Biologics Pte. Ltd. via NYB Holdings remains subject to closing conditions.
- Quorum of 7,206,188 shares (86.36%) present; record date May 20, 2026.
- Redemption requests may be withdrawn with consent; final per-share price and trust proceeds pending closing.

## SEC filing metadata
- accession: 0001829126-26-009168
- form_type: 8-K
- ticker: RFAI
- cik: 0002012807
- company_name: RF Acquisition Corp II
- filed_at: 2026-08-20T20:49:43+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2012807/000182912626009168/0001829126-26-009168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2012807/000182912626009168/rfacquisition2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-009168
- JSON: https://secwatch.observer/filing/0001829126-26-009168.json
- Plain text: https://secwatch.observer/filing/0001829126-26-009168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.